The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Global burden of gastric cancer attributable to Helicobacterpylori: Helicobacter pylori in gastric cancer
Abstract
We previously estimated that 660,000 cases of cancer in the year 2008 were attributable to the bacterium Helicobacter pylori (H. pylori), corresponding to 5.2% of the 12.7 million total cancer cases that occurred worldwide. In recent years, evidence has accumulated that immunoblot (western blot) is more sensitive for detection of anti-H. pylori antibodies than ELISA, the detection method used in our previous analysis. The purpose of this short report is to update the attributable fraction (AF) estimate for H. pylori after briefly reviewing new evidence, and to reassess the global burden of cancer attributable to H. pylori. We therefore reviewed the literature for studies comparing the risk of developing non-cardia gastric cancer (NCGC) in cases and controls, using both ELISA and multiple antigen immunoblot for detection of H. pylori. The results from prospective studies were combined, and the new pooled estimates were applied to the calculation of the AF for H. pylori in NCGC, then to the burden of infection-related cancers worldwide. Using the immunoblot-based data, the worldwide AF for H. pylori in NCGC increased from 74.7% to 89.0%. This implies approximately 120,000 additional cases of NCGC attributable to H. pylori infection for a total of around 780,000 cases (6.2% instead of 5.2% of all cancers). These updated estimates reinforce the role of H. pylori as a major cause of cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Self-citationGlobal burden of cancers attributable to infections in 2008: a review and synthetic analysis
de Martel, C., Ferlay, J., Franceschi, S., Vignat, J., Bray, F., Forman, D., & Plummer, M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70137-7 · Cited by 2,534
Self-citationHelicobacter and Cancer Collaborative Group (2001) · Gut · doi:10.1136/gut.49.3.347 · Cited by 1,038
Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection
Ekström, A. M., Held, M., Hansson, L.-E., Engstrand, L., & Nyrén, O. (2001) · Gastroenterology · doi:10.1053/gast.2001.27999 · Cited by 432
Is Helicobacter pylori Infection a Necessary Condition for Noncardia Gastric Cancer?
Brenner, H. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh039 · Cited by 193
Monteiro, L. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(00)02311-x · Cited by 184
Gonzalez, C. A., Figueiredo, C., Lic, B. C., Ferreira, R. M., Pardo, M. L., Liso, R. J. M., Alonso, P., Sala, N., Capellá, G., & Anquela, J. M. S. (2011) · The American Journal of Gastroenterology · doi:10.1038/ajg.2011.1 · Cited by 141
Gonzalez, C. A., Mégraud, F., Buissonnière, A., Luján‐Barroso, L., Agudo, A., Duell, E. J., Boutron‐Ruault, M., Clavel‐Chapelon, F., Palli, D., Krogh, V., et al. (2011) · Annals of Oncology · doi:10.1093/annonc/mdr384 · Cited by 132
Helicobacter pylori Cytotoxin-Associated Genotype and Gastric Precancerous Lesions
Plummer, M., Doorn, L. J. V., Franceschi, S., Kleter, B., Canzian, F., Vivas, J. H., Lopez, G., Colin, D., Munoz, N., & Kato, I. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm120 · Cited by 115
Self-citationSimán, H., Forsgren, A., Berglund, G., & Florén, C. ‐. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709028150 · Cited by 71
Cited by
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Global Cancer Incidence and Mortality Rates and Trends—An Update
Torre, L. A., Siegel, R. L., Ward, E. M., & Jemal, A. (2016) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0578 · Cited by 3,692
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
de Martel, C., Georges, D., Bray, F., Ferlay, J., & Clifford, G. M. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30488-7 · Cited by 2,475
Self-citationGlobal burden of cancers attributable to infections in 2012: a synthetic analysis
Plummer, M., de Martel, C., Vignat, J., Ferlay, J., Bray, F., & Franceschi, S. (2016) · The Lancet Global Health · doi:10.1016/s2214-109x(16)30143-7 · Cited by 1,635
Self-citationManagement of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Thrift, A. P., & El-Serag, H. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.045 · Cited by 1,456
Malfertheiner, P., Camargo, M. C., El-Omar, E., Liou, J.-M., Peek, R., Schulz, C., Smith, S. I., & Suerbaum, S. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00431-8 · Cited by 1,191
Epidemiology of Helicobacter pylori infection
Leja, M., Axon, A., & Brenner, H. (2016) · Helicobacter · doi:10.1111/hel.12332 · Cited by 880
Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention
Thrift, A. P., Wenker, T. N., & El-Serag, H. B. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00747-0 · Cited by 828
Chen, Y.-C., Malfertheiner, P., Yu, H.-T., Kuo, C.-L., Chang, Y.-Y., Meng, F.-T., Wu, Y.-X., Hsiao, J.-L., Chen, M.-J., Lin, K.-P., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2023.12.022 · Cited by 554
Updates on global epidemiology, risk and prognostic factors of gastric cancer
Yang, W.-J., Zhao, H.-P., Yu, Y., Wang, J.-H., Guo, L., Liu, J.-Y., Pu, J., & Lv, J. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i16.2452 · Cited by 513
Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
Arnold, M., Park, J. Y., Camargo, M. C., Lunet, N., Forman, D., & Soerjomataram, I. (2020) · Gut · doi:10.1136/gutjnl-2019-320234 · Cited by 504
Self-citationLiou, J.-M., Malfertheiner, P., Lee, Y.-C., Sheu, B.-S., Sugano, K., Cheng, H.-C., Yeoh, K.-G., Hsu, P.-I., Goh, K.-L., Mahachai, V., et al. (2020) · Gut · doi:10.1136/gutjnl-2020-322368 · Cited by 493
Cancer and Mediterranean Diet: A Review
Mentella, M. C., Scaldaferri, F., Ricci, C., Gasbarrini, A., & Miggiano, G. A. D. (2019) · Nutrients · doi:10.3390/nu11092059 · Cited by 478
Cancer statistics for Hispanics/Latinos, 2015
Siegel, R. L., Fedewa, S. A., Miller, K. D., Goding‐Sauer, A., Pinheiro, P. S., Martinez‐Tyson, D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21314 · Cited by 468
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection
Chey, W. D., Howden, C. W., Moss, S. F., Morgan, D. R., Greer, K. B., Grover, S., & Shah, S. C. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002968 · Cited by 419
Global Incidence and Mortality of Gastric Cancer, 1980-2018
Wong, M. C. S., Huang, J., Chan, P. S. F., Choi, P., Lao, X. Q., Chan, S. M., Teoh, A., & Liang, P. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2021.18457 · Cited by 408
Torre, L. A., Sauer, A. M. G., Chen, M. S., Kagawa‐Singer, M., Jemal, A., & Siegel, R. L. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21335 · Cited by 393
How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013
Wilson, L. F., Antonsson, A., Green, A. C., Jordan, S. J., Kendall, B. J., Nagle, C. M., Neale, R. E., Olsen, C. M., Webb, P. M., & Whiteman, D. C. (2018) · International Journal of Cancer · doi:10.1002/ijc.31088 · Cited by 391
Changing Trends in Stomach Cancer Throughout the World
Balakrishnan, M., George, R., Sharma, A., & Graham, D. Y. (2017) · Current Gastroenterology Reports · doi:10.1007/s11894-017-0575-8 · Cited by 384
Global patterns of cardia and non-cardia gastric cancer incidence in 2012
Colquhoun, A., Arnold, M., Ferlay, J., Goodman, K. J., Forman, D., & Soerjomataram, I. (2015) · Gut · doi:10.1136/gutjnl-2014-308915 · Cited by 383
Self-citationCancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening?
Shah, S. C., Kayamba, V., Peek, R. M., & Heimburger, D. (2019) · Journal of Global Oncology · doi:10.1200/jgo.18.00200 · Cited by 382
Signaling pathways and therapeutic interventions in gastric cancer
Lei, Z.-N., Teng, Q.-X., Tian, Q., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z.-S., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 322
The Clinical Evidence Linking Helicobacter pylori to Gastric Cancer
Moss, S. F. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2016.12.001 · Cited by 321
AGA clinical practice guidelines on management of gastric intestinal metaplasia
Gupta, S., Li, D., El Serag, H. B., Davitkov, P., Altayar, O., Sultan, S., Falck-Ytter, Y., & Mustafa, R. A. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.12.003 · Cited by 320
Naghavi, M., Mestrovic, T., Gray, A., Gershberg Hayoon, A., Swetschinski, L. R., Robles Aguilar, G., Davis Weaver, N., Ikuta, K. S., Chung, E., Wool, E. E., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00158-0 · Cited by 311
Fallone, C. A., Moss, S. F., & Malfertheiner, P. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.04.011 · Cited by 286
Yang, L., Kartsonaki, C., Yao, P., de Martel, C., Plummer, M., Chapman, D., Guo, Y., Clark, S., Walters, R. G., Chen, Y., et al. (2021) · The Lancet Public Health · doi:10.1016/s2468-2667(21)00164-x · Cited by 205
Self-citationCancer in Africa 2018: The role of infections
Parkin, D. M., Hämmerl, L., Ferlay, J., & Kantelhardt, E. J. (2020) · International Journal of Cancer · doi:10.1002/ijc.32538 · Cited by 130
Monteagudo-Mera, A., Arthur, J. C., Jobin, C., Keku, T., Bruno-Barcena, J. M., & Azcarate-Peril, M. A. (2016) · Beneficial Microbes · doi:10.3920/bm2015.0114 · Cited by 112
Prevalence of major risk factors and use of screening tests for cancer in the United States
Fedewa, S. A., Sauer, A. G., Siegel, R. L., & Jemal, A. (2015) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0134 · Cited by 77
Che, H., Xiong, Q., Ma, J., Chen, S., Wu, H., Xu, H., & Hou, B. (2022) · BMC Cancer · doi:10.1186/s12885-022-10004-9 · Cited by 74
Toyoshima, O., Yamaji, Y., Yoshida, S., Matsumoto, S., Yamashita, H., Kanazawa, T., & Hata, K. (2017) · Surgical Endoscopy · doi:10.1007/s00464-016-5211-4 · Cited by 59
Mommersteeg, M. C., Eikenboom, E. L., Nieuwenburg, S. A. V., Yu, B., den Hollander, W. J., Holster, I. L., den Hoed, C. M., Capelle, L. G., Tang, T. J., Anten, M.-P., et al. (2021) · Endoscopy International Open · doi:10.1055/a-1314-6626 · Cited by 27
Blanc, M., Lettl, C., Guérin, J., Vieille, A., Furler, S., Briand-Schumacher, S., Dreier, B., Bergé, C., Plückthun, A., Vadon-Le Goff, S., et al. (2023) · PLOS Pathogens · doi:10.1371/journal.ppat.1011368 · Cited by 9
Li, G., Huo, D., Guo, N., Li, Y., Ma, H., Liu, L., Xie, H., Zhang, D., Qu, B., & Chen, X. (2023) · Frontiers in Genetics · doi:10.3389/fgene.2023.1106724 · Cited by 5
Metadata
- Authors
- Plummer, M., Franceschi, S., Vignat, J., Forman, D., & de Martel, C.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2014-06-11
- Volume
- 136
- Issue
- 2
- Pages
- 487-490
- ISSN
- 0020-7136 (ISSN-L)
- OpenAlex
- W2147496191
- Cited by
- 957
- References
- 14
- FWCI
- 38.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.